Table 4 Risk factors for surgery in patient with IMIDs in univariate and multivariate analysis.

From: Impact of immune-mediated diseases in inflammatory bowel disease and implications in therapeutic approach

 

Univariate analysis

Multivariate analysis

Adjusted hazard ratio

CI

Adjusted hazard ratio

CI

IMIDs prior to IBD

2.36

1.45–3.85

3.71

2.1–6.56

Complications

2.44

1.47–4.06

1.07

0.56–2.07

Perianal disease

1.63

1.00–2.68

1.7

1.03–2.79

Immunomodulator therapy

1.19

0.92–1.55

0.47

0.25–0.88

Biological therapy

0.85

0.65–1.23

2.17

1.24–3.82

Back to article page